CN
CN

News

2026-02-05
Han Kun Advises Everest Medicines on Exclusive License Agreement with Micot to Commercialize MT1013, a Dual-Targeting Receptor Agonist Polypeptide Targeting CaSR/OGP
2026-02-05
Han Kun partner Ying Zeng honored among LEGALBAND's 2025 Top 15 Investment Dispute Resolution Lawyers
2026-02-05
Han Kun partner Jolie Yan honored among LEGALBAND's 2025 Top 15 White-Collar Crime & Commercial Crime Lawyers
2026-02-04
Han Kun advises on Zhejiang Construction Investment Group Co., Ltd.'s share issuance for asset acquisition and fundraising
2026-02-03
Han Kun wins "Best Legal Counsel (CN)" and three deal awards at CSCI DMI Awards 2025
2026-02-02
Han Kun partner Yan Zhang honored among LegalOne's Blue Ribbon 2025: Highly Recommended 15 for Construction and Real Estate Disputes
2026-01-28
Han Kun acts as data compliance advisor for Busy Ming's Hong Kong listing
2026-01-23
Han Kun and Han Kun Hong Kong Jointly Assist Industrial Bank FTZ Branch in Issuing RMB3 Billion Yulan Bonds--the First Yulan Bonds by a Free Trade Zone Institution in the Market
2026-01-15
Chambers Greater China Region Guide 2026 highly recommends multiple Han Kun lawyers and practice areas
2026-01-14
Han Kun Advises Zonsen PepLib Biotech Inc. on the Landmark Global Exclusive Licensing Collaboration with Novartis for A Radioligand Therapy Asset
2026-01-12
17 Han Kun Lawyers named to China Business Law Journal's The A-List 2025-26: Growth Drivers
2026-01-10
Han Kun partner Lili Wu wins CLECSS's "Most Influential Women Lawyers Award"
Year
  • «
  • 1
  • 2
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 137
  • 138
  • »
  • Han Kun
    Send regular emails covering market and industry trends.
    Subscribe